Bosutinib
- Level
- Commodity
- Parent
- 51112000
- Below
- 0
- Links · KBLI
- 8
Definition
UNSPSC 51112019This classification denotes a tyrosine kinase inhibitor with the molecular structure C26H29CL2N5O3, a preparation that US FDA recognizes as an active ingredient or moiety under Unique Ingredient Identifier, 5018V4AEZ0 chemically known as 3-quinolinecarbonitrile, 4-((2,4-dichloro-5-methoxyphenyl)amino)-6-methyl-1-piperazinyl)propoxy)-, but more commonly known as bosutinib, which bears U.S. National Institutes of Health Compound Identifier 5328940. European Medicines Agency schedules Bosutinib in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB29176. The term BOSUTINIB is an International Non-Proprietary Name or INN (see World Health Organization INN reference publication, volume 20, no. 3, 2006, list 56).
Same parent
Under 51112000 · 37Activities that produce or sell this
KBLI · 8Inherited from family 51110000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.